The Coalition for Epidemic Preparedness Innovations (CEPI) says it will provide up to $16.5 million to Minapharm Group to advance…
Browsing: CEPI
The Coalition for Epidemic Preparedness Innovations (CEPI) has warned that a $185 million funding gap could undermine efforts to develop…
West African countries are making significant progress in preparing for Lassa fever vaccines, with three candidates currently under development. This…
The Africa Centres for Disease Control and Prevention (Africa CDC) has raised the alarm over antimicrobial resistance (AMR), describing it…
The Coalition for Epidemic Preparedness Innovations (CEPI) has inaugurated a five-year strategy aimed at strengthening global preparedness against epidemic and…
West African countries have taken a major step toward strengthening regional epidemic preparedness with the inauguration of the first End-to-End…
Amid an outbreak of Rift Valley fever (RVF) in West Africa, the University of Oxford and the Serum Institute of…
The World Health Organization (WHO) has identified Lassa fever as a priority pathogen in urgent need of research and development…
The global fight against Lassa fever has taken a major step forward as the Oxford Vaccine Group administered the first…
The Coalition for Epidemic Preparedness Innovations (CEPI), says studies are underway to conduct clinical trials to develop a vaccine for Lassa fever in West Africa.